[Latest] Global Flexible Plastic Packaging Market Size/Share Worth USD 293.7 Billion by 2033 at a 5.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
May 22, 2024 12:30 ET
|
Custom Market Insights
Austin, TX, USA, May 22, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Flexible Plastic Packaging Market Size, Trends and Insights By Product Type...
Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL Congress™ 2024
May 22, 2024 08:00 ET
|
Assembly Biosciences, Inc.
-- Preclinical data from both ABI-5366 and ABI-1179, Assembly Bio’s long-acting helicase-primase inhibitor candidates targeting recurrent genital herpes, featured in poster and oral presentations at...
Malonic Acid Market Is Expected To Reach Revenue Of USD 169.0 Mn By 2033, At 3.2% CAGR: Dimension Market Research
May 21, 2024 13:41 ET
|
Dimension Market Research
New York, May 21, 2024 (GLOBE NEWSWIRE) -- Market Overview Global Malonic Acid Market size is expected to reach USD 127.1 million by 2024 and is further anticipated to reach USD 169.0...
Dalrada Financial Corporation Healthcare Subsidiary, Genefic, Inc., Acquires IV Services Infusion Pharmacy
May 21, 2024 08:45 ET
|
Dalrada Financial Corp.
Company enters $42 billion marketplace with acquisition of established and successful infusion pharmacy.
Telix Completes Proof-of-Concept Study of TLX592 Targeted Alpha Therapy in Prostate Cancer
May 20, 2024 19:46 ET
|
Telix Pharmaceuticals Limited
CUPID is a Phase I safety and dosimetry study of TLX592, Telix’s investigational antibody-based targeted alpha therapy for prostate cancer.Establishes proof-of-concept for Telix’s proprietary RADmAb®...
Aerami Therapeutics Presents New Lung Deposition Modeling Data For AER-901 in Pulmonary Hypertension at the American Thoracic Society 2024 International Conference
May 20, 2024 17:00 ET
|
Aerami Therapeutics Inc
DURHAM, N.C., May 20, 2024 (GLOBE NEWSWIRE) -- Aerami Therapeutics (“Aerami”), a clinical stage biopharmaceutical company dedicated to breathing life into the treatment of serious and rare...
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Avril 2024
May 20, 2024 16:54 ET
|
Sanofi - Aventis Groupe
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés...
Sanofi: Information concerning the total number of voting rights and shares - April 2024
May 20, 2024 16:54 ET
|
Sanofi - Aventis Groupe
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement...
Lumos Pharma Announces Abstracts Accepted for Presentation at ENDO 2024
May 20, 2024 16:05 ET
|
Lumos Pharma, Inc.
AUSTIN, Texas, May 20, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical stage biopharmaceutical company focused on therapeutics for rare diseases, announced today that new...
More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024
May 17, 2024 13:45 ET
|
Regeneron Pharmaceuticals, Inc.
TARRYTOWN, N.Y. and WASHINGTON, D.C., May 17, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Society for Science (the Society) announced that Grace Sun, 16, of...